Risk of Serious Infections Associated With Novel Advanced Therapies for IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Clin. Gastroenterol. Hepatol. 2023 Apr 01;21(4)907-921.e2, V Solitano, A Facciorusso, T Jess, C Ma, C Hassan, A Repici, V Jairath, A Armuzzi, S SinghFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.